Faul C M, Mirmow D, Huang Q, Gerszten K, Day R, Jones M W
Department of Radiation Oncology, Magee Women's Hospital, University of Pittsburgh Medical School, PA 15213, USA.
Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):381-9. doi: 10.1016/s0360-3016(97)82500-x.
Local recurrence is a significant problem following primary surgery for advanced vulva carcinoma. The objectives of this study were to evaluate the impact of adjuvant vulvar radiation on local control in high risk patients and the impact of local recurrence on overall survival.
From 1980-1994, 62 patients with invasive vulva carcinoma and either positive or close (less 8 mm) margins of excision were retrospectively studied. Thirty-one patients were treated with adjuvant radiation therapy to the vulva and 31 patients were observed after surgery. Kaplan-Meier estimates and the Cox proportional hazard regression model were used to evaluate the effect of adjuvant radiation therapy on local recurrence and overall survival. Independent prognostic factors for local recurrence and survival were also assessed.
Local recurrence occurred in 58% of observed patients and 16% in patients treated with adjuvant radiation therapy. Adjuvant radiation therapy significantly reduced local recurrence rates in both the close margin and positive margin groups (p = 0.036, p = 0.0048). On both univariate and multivariate analysis adjuvant radiation and margins of excision were significant prognostic predictors for local control. Significant determinants of actuarial survival included International Federation of Gynecologists and Obstetricians (FIGO) stage, percentage of pathologically positive inguinal nodes and margins of excision. The positive margin observed group had a significantly poorer actuarial 5 year survival than the other groups (p = 0.0016) and adjuvant radiation significantly improved survival for this group. The 2 year actuarial survival after developing local recurrence was 25%. Local recurrence was a significant predictor for death from vulva carcinoma (risk ratio 3.54).
Local recurrence is a common occurrence in high risk patients. In this study adjuvant radiation therapy significantly reduced local recurrence rates and may improve overall survival in certain subgroups. As salvage rates after developing local recurrence are poor adjuvant vulvar radiation should be considered for patients at risk after primary surgery.
局部复发是晚期外阴癌初次手术后的一个重要问题。本研究的目的是评估辅助性外阴放疗对高危患者局部控制的影响以及局部复发对总生存的影响。
对1980年至1994年间62例浸润性外阴癌且手术切缘阳性或切缘距离很近(小于8毫米)的患者进行回顾性研究。31例患者接受了外阴辅助放疗,31例患者术后接受观察。采用Kaplan-Meier估计法和Cox比例风险回归模型来评估辅助放疗对局部复发和总生存的影响。还评估了局部复发和生存的独立预后因素。
观察的患者中有58%发生局部复发,接受辅助放疗的患者中这一比例为16%。辅助放疗显著降低了切缘距离很近组和切缘阳性组的局部复发率(p = 0.036,p = 0.0048)。单因素和多因素分析均显示,辅助放疗和手术切缘是局部控制的重要预后预测因素。精算生存的重要决定因素包括国际妇产科联盟(FIGO)分期、腹股沟淋巴结病理阳性百分比和手术切缘。切缘阳性的观察组5年精算生存率明显低于其他组(p = 0.0016),辅助放疗显著改善了该组的生存情况。发生局部复发后的2年精算生存率为25%。局部复发是外阴癌死亡的重要预测因素(风险比3.54)。
局部复发在高危患者中很常见。在本研究中,辅助放疗显著降低了局部复发率,并可能改善某些亚组的总生存。由于局部复发后的挽救率较低,对于初次手术后有风险的患者应考虑进行辅助性外阴放疗。